Log in or Sign up for Free to view tailored content for your specialty!
Headline News
Study provides more positive data for Paxlovid use in high-risk patients with COVID-19
Treatment with Paxlovid significantly reduced the duration and severity of SARS-CoV-2 infection among high-risk patients while also reducing health care utilization and severe outcomes, according to a study.
Action needed to increase diversity, address race, gender gaps in nephrology
SAN DIEGO — Increasing diversity and addressing gender and racial gaps among nephrology fellows requires immediate action, researchers said at ASN Kidney Week.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa
The FDA has approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults, UCB announced in a press release.
VIDEO: Repeat exposure to mesh glue dressing may increase allergic contact dermatitis risk
DALLAS — In this video from the American Association of Hip and Knee Surgeons Annual Meeting, Robert A. Burnett, MD, discussed results that showed repeat mesh glue dressing exposure yielded a fivefold increased risk of allergic dermatitis.
Challenges remain in anaphylaxis diagnosis despite consensus criteria
BOSTON — Consensus criteria for anaphylaxis diagnosis are moving toward more objective assessments of symptoms, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Dalzanemdor fails to meet endpoints in phase 2 study of patients with Huntington’s disease
A phase 2 clinical trial of dalzanemdor in those with cognitive impairment associated with Huntington’s disease failed to meet its primary and secondary endpoints, causing the manufacturer to halt development of the investigational therapy.
‘A valuable treatment’: Roflumilast foam 0.3% shows positive PROs in scalp, body psoriasis
Roflumilast foam 0.3% improved patient-reported outcomes in scalp and body psoriasis, according to a poster presentation at the Fall Clinical Dermatology Conference.
Top in endocrinology: Daily oral semaglutide for weight loss; intuitive eating
Results from the OASIS 4 trial revealed that people with overweight or obesity assigned to once-daily oral semaglutide had a higher likelihood of significant weight loss compared with those receiving placebo plus lifestyle intervention.
Opioid awareness, Part 2: Stomping the stigma and a mom’s view, with Cammie Wolf Rice
In this episode, guest Cammie Wolf Rice discusses the opioid crisis, how it impacted her life and family and her foundation’s mission to combating the epidemic and spreading awareness.
Intertrochanteric femur fractures with compromised proximal fixation may have nail toggle
Results presented at the Orthopaedic Trauma Association Annual Meeting showed short proximal femoral nails may toggle secondary to a proximal fixation defect if used for intertrochanteric fractures in patients with wide medullary canals.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read